Recovery of T-cell subsets after antiretroviral therapy in HIV-infected children

被引:6
|
作者
Resino, S
Bellón, JM
Gurbindo, D
León, JA
Muñoz-Fernández, MA
机构
[1] Hosp Gen Univ Gregorio Maranon, Dept Inmunol, Madrid 28007, Spain
[2] Hosp Gen Univ Gregorio Maranon, Dept Paediat, Madrid 28007, Spain
[3] Univ Hosp Virgen Rocio, Dept Paediat, Paediat Infect Dis Unit, Seville, Spain
关键词
antiretroviral therapy; CD4 T cells; children; HIV-1; T-cell subsets; viral load;
D O I
10.1046/j.1365-2362.2003.01168.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Variation of percentageCD4+ T cells may accurately reflects the kinetics of a comprehensive immune recovery independently of the antiretroviral (ART) regimen. To test this we have investigated the relationship among peripheral blood T-cell subsets with the variation of percentageCD4+ T cells during follow up in 49 HIV-infected children. Methods Children were divided into two groups according to the sign of slope percentageCD4+ T cell during follow up: Ps-group (positive slope) and Ns-group (negative percentageCD4 slope) indicative of immunological recovery or not, respectively. CD4+ and CD8+ T-cell subset percentages were examined by three-colour flow cytometry. Results We found higher memory CD4+ and CD8+ T-cell percentages in the Ns-group than in the Ps-group, and inversely, higher naive CD4+ and CD8+ T cells in the Ps-group than in the Ns-group. CD4+ and CD8+ subsets in the Ps-group expressed higher levels of CD38+ and lower levels of HLA-DR+ compared with the Ns-group. We found a very strong positive correlation among the slope of percentageCD4+, CD4+ CD38+, whereas a negative correlation among the slope of percentageCD4+, the CD8+ CD28+ CD57+ and CD8+ CD57+ T-cell subsets. Conclusion Recovery of the CD4+ T-cell percentage induced by ART reflects a reduction in the chronic immune activation and a measurable reconstitution of the immune system and depends on naive CD4+ T cells.
引用
收藏
页码:619 / 627
页数:9
相关论文
共 50 条
  • [21] INTRACELLULAR GLUTATHIONE LEVELS IN T-CELL SUBSETS DECREASE IN HIV-INFECTED INDIVIDUALS
    STAAL, FJT
    ROEDERER, M
    ISRAELSKI, DM
    BUBP, J
    MOLE, LA
    MCSHANE, D
    DERESINSKI, SC
    ROSS, W
    SUSSMAN, H
    RAJU, PA
    ANDERSON, MT
    MOORE, W
    ELA, SW
    HERZENBERG, LA
    HERZENBERG, LA
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) : 305 - 311
  • [22] Adherence with antiretroviral therapy in HIV-infected children.
    Schuval, SJ
    DeSarbo, J
    Mamonluk, M
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S214 - S214
  • [23] Progress and challenges in antiretroviral therapy for HIV-infected children
    Rosenberg M.G.
    Abadi J.
    Dobroszycki J.
    Wiznia A.
    Current Infectious Disease Reports, 2006, 8 (4) : 324 - 331
  • [24] Adherence to antiretroviral therapy in HIV-infected children in Italy
    Albano, F
    Spagnuolo, MI
    Canani, RB
    Guarino, A
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 1999, 11 (06): : 711 - 714
  • [25] Hepatotoxicity in HIV-infected children and adolescents on antiretroviral therapy
    Mantes Gil, Am Cecilia
    Lorenzetti, Raquel
    Mendes, Gun Bergsten
    Morcillo, Andre Moreno
    Dalbo Contreras Toro, Adyleia Aparecida
    Nolasco do Silva, Marcos Tadeu
    dos Santos Vilela, Maria Marluce
    SAO PAULO MEDICAL JOURNAL, 2007, 125 (04): : 205 - 209
  • [26] Guideline for Antiretroviral Therapy of HIV-Infected Children and Adolescents
    Neubert, J.
    Niehues, T.
    Baumann, U.
    Buchholz, B.
    Notheiss, G.
    Wintergerst, U.
    Blume, J.
    Feiterna-Sperling, C.
    Laws, H. -J
    Linde, R.
    Koenigs, C.
    KLINISCHE PADIATRIE, 2012, 224 (02): : 98 - 110
  • [27] When to initiate antiretroviral therapy in HIV-infected children?
    Thuret, I
    ARCHIVES DE PEDIATRIE, 2004, 11 (12): : 1521 - 1524
  • [28] T-CELL ACTIVATION OF HIV-INFECTED MOTHERS AND THEIR SUSCEPTIBLE CHILDREN
    CAFARO, A
    SCARLATTI, G
    LOMBARDI, V
    ALBERT, J
    ROSSI, P
    WAHREN, B
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (02) : 204 - 204
  • [29] Metabolic complications of antiretroviral therapy in HIV-infected children
    Eley, Brian
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (01) : 37 - 49
  • [30] Rosuvastatin Reduces Vascular Inflammation and T-cell and Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy
    Funderburg, Nicholas T.
    Jiang, Ying
    Debanne, Sara M.
    Labbato, Danielle
    Juchnowski, Steven
    Ferrari, Brian
    Clagett, Brian
    Robinson, Janet
    Lederman, Michael M.
    McComsey, Grace A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 68 (04) : 396 - 404